• English
  • 简体中文
Login Register
Current Location: Home > CFDA Approvals(Domestic) Feedback Help
Latest Data
-
-
-
Historical Data
-
-
-
-
-
Export
Drug Name Active Ingredient Dosage Form Strength Manufacturers Manufacturers Approval No. Same Variety(Same Strength) Approval Date Drug Classification Details
去氨加压素注射液 desmopressin acetate Injection 1ml:13.35μg(按C46H64N14O12S2计) 南京星银药业集团有限公司 Nanjing Xingyin Pharmaceutical Group Co Ltd 国药准字H20213126 view 2021-02-10 Medicare(class A) view
去氨加压素注射液 desmopressin acetate Injection 1ml:13.35μg(按C46H64N14O12S2计) 海南中和药业股份有限公司 Hainan Zhonghe Pharmaceutical Co Ltd 国药准字H20065070 view 2021-04-15 Medicare(class A) view
去氨加压素注射液 desmopressin acetate Injection 1ml﹕15μg 深圳翰宇药业股份有限公司 Hybio Pharmaceutical Co Ltd 国药准字H20064094 view 2020-09-27 Medicare(class A) view
去氨加压素注射液 desmopressin acetate Injection 1ml:4μg 深圳翰宇药业股份有限公司 Hybio Pharmaceutical Co Ltd 国药准字H20064093 view 2020-09-27 Medicare(class A) view
去氨加压素注射液 desmopressin acetate Injection 1ml:3.56μg(按C46H64N14O12S2计) 海南中和药业股份有限公司 Hainan Zhonghe Pharmaceutical Co Ltd 国药准字H20065069 view 2021-04-15 Medicare(class A) view
去氨加压素注射液 desmopressin acetate Injection 1ml:3.56μg(按C46H64N14O12S2计) 南京星银药业集团有限公司 Nanjing Xingyin Pharmaceutical Group Co Ltd 国药准字H20213125 view 2021-02-10 Medicare(class A) view
去氨加压素注射液 desmopressin acetate Injection 1ml : 13.35μg(按C₄₆H₆₄N₁₄O₁₂S₂计) 成都利尔药业有限公司 Beijing Baiao Pharmaceuticals Co Ltd 国药准字H20233401 view 2023-04-04 Medicare(class A) view